Personal information

Activities

Works (2)

Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study

American Journal of Hematology
2023-11 | Journal article
Contributors: Lijuan Deng; Zhiming Li; Huilai Zhang; Haiwen Huang; Jianda Hu; Lihong Liu; Ting Liu; Jie Jin; Zunmin Zhu; Wenyu Li et al.
Source: check_circle
Crossref

Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma

Journal of Cancer Research and Clinical Oncology
2021-11 | Journal article
Contributors: Qian Wang; Yibin Jiang; Qian Zhu; Yishan Duan; Xiaochen Chen; Ting Xu; Zhengming Jin; Caixia Li; Depei Wu; Haiwen Huang
Source: check_circle
Crossref